PIGU

phosphatidylinositol glycan anchor biosynthesis class U, the group of Phosphatidylinositol glycan anchor biosynthesis|Glycosylphosphatidylinositol transamidase complex

Basic information

Region (hg38): 20:34560542-34698790

Previous symbols: [ "CDC91L1" ]

Links

ENSG00000101464NCBI:128869OMIM:608528HGNC:15791Uniprot:Q9H490AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • glycosylphosphatidylinositol biosynthesis defect 21 (Strong), mode of inheritance: AR
  • glycosylphosphatidylinositol biosynthesis defect 21 (Moderate), mode of inheritance: AR
  • glycosylphosphatidylinositol biosynthesis defect 21 (Strong), mode of inheritance: AR
  • glycosylphosphatidylinositol biosynthesis defect 21 (Limited), mode of inheritance: AD
  • glycosylphosphatidylinositol biosynthesis defect 21 (Limited), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Neurodevelopmental disorder with brain anomalies, seizures, and scoliosisARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingBiochemical; Craniofacial; Musculoskeletal; Neurologic; Ophthalmologic31353022

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PIGU gene.

  • not_provided (95 variants)
  • Glycosylphosphatidylinositol_biosynthesis_defect_21 (10 variants)
  • PIGU-related_disorder (7 variants)
  • Inborn_genetic_diseases (7 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PIGU gene is commonly pathogenic or not. These statistics are base on transcript: NM_000080476.5. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
3
clinvar
31
clinvar
1
clinvar
35
missense
2
clinvar
38
clinvar
3
clinvar
1
clinvar
44
nonsense
1
clinvar
1
start loss
1
1
frameshift
1
clinvar
1
splice donor/acceptor (+/-2bp)
0
Total 2 1 43 34 2

Highest pathogenic variant AF is 0.000013010685

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PIGUprotein_codingprotein_codingENST00000217446 12116565
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.00001900.9751257220261257480.000103
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.7212082390.8690.00001262838
Missense in Polyphen7391.3450.799171180
Synonymous-0.54610497.21.070.00000558857
Loss of Function2.031121.10.5228.92e-7268

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0003240.000324
Ashkenazi Jewish0.0004970.000496
East Asian0.0001090.000109
Finnish0.00004640.0000462
European (Non-Finnish)0.00002700.0000264
Middle Eastern0.0001090.000109
South Asian0.0001320.000131
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Component of the GPI transamidase complex. May be involved in the recognition of either the GPI attachment signal or the lipid portion of GPI. {ECO:0000269|PubMed:12802054}.;
Pathway
Glycosylphosphatidylinositol (GPI)-anchor biosynthesis - Homo sapiens (human);Attachment of GPI anchor to uPAR;Post-translational modification: synthesis of GPI-anchored proteins;Post-translational protein modification;Metabolism of proteins (Consensus)

Recessive Scores

pRec
0.111

Intolerance Scores

loftool
0.145
rvis_EVS
-0.4
rvis_percentile_EVS
26.73

Haploinsufficiency Scores

pHI
0.178
hipred
Y
hipred_score
0.530
ghis
0.609

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
H
gene_indispensability_pred
E
gene_indispensability_score
0.634

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Pigu
Phenotype
nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);

Zebrafish Information Network

Gene name
pigu
Affected structure
Rohon-Beard neuron
Phenotype tag
abnormal
Phenotype quality
increased age

Gene ontology

Biological process
GPI anchor biosynthetic process;attachment of GPI anchor to protein;protein localization to cell surface;regulation of JAK-STAT cascade
Cellular component
endoplasmic reticulum membrane;plasma membrane;membrane;integral component of endoplasmic reticulum membrane;GPI-anchor transamidase complex
Molecular function
GPI-anchor transamidase activity;GPI anchor binding